TTR and neoplasm: In the β-catenin-prostate set used for development, patients with tumours with low β-catenin expression did not have significantly shorter TTR compared to patients with high β-catenin expression tumours when scored manually (HR = 1.49, 95 % CI 0.93–2.39, Fig. 6 (A), Table 2), but this association was significant when using DL scores (HR = 2.13, 95 % CI 1.35–3.37, Fig. 6 (B)–Table 2).